CAT-07-ADC

N/A

Report date: 2025/01/26 17:42:04

Base Information

Drug NameCAT-07-ADC
Drug Alias Nameanti-GPC3 antibody-drug conjugate (Catalent)CAT-07-ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionGlypican-3 inhibitors
TargetsGlypican-3
Therapy Area/IndicationsLung NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCatalent Inc
China Registration ClassN/A

Develop Information

Active CompaniesCatalent Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A